Pharmaceuticals
Clarification on some aspects of the European Medicine Agency’s revised ERA guidance
February 6, 2026 by Olivia Tran
The European Medicines Agency (EMA) held a webinar on the revised guideline for the environmental risk assessment (ERA) of human pharmaceuticals in October 2025, and a summary…
Recent experience in implementing the European Medicine Agency’s revised ERA guidance
January 13, 2026 by Olivia Tran
wca have been working with pharmaceutical innovators and generics companies on environmental risk assessments (ERA) since the European Medicines Agency (EMA) published their original guidance on conducting ERAs in 2006.
Approaches to meet the new Pharmaceutical Environmental Risk Assessment Guidance
November 20, 2024 by Becky Brown
New guidance for the European Medicine Agencies (EMA) pharmaceutical environmental risk assessment (ERA) were published in February 2024, effective from September 2024. The new ERA guidance leads…
Pharmaceuticals in the Environment – a Global Challenge Session at SETAC Europe
May 10, 2021 by Dean Leverett
I co-chaired a live virtual discussion on Pharmaceuticals in the Environment in the final session block of SETAC Europe 2021. The discussion was split into three blocks, each covering a…
Perspectives on Relevancy Assessment for Non Standard Ecotoxicity Data in Environment Quality Standard derivation: Examples for Diclofenac
October 15, 2020 by Graham Merrington
Graham, Adam and Dean have just published the paper “Perspectives on Relevancy Assessment for Non Standard Ecotoxicity Data in Environment Quality Standard derivation: Examples for Diclofenac” in Bulletin…
From our blog
March 9, 2026 by Iain Wilson
March 3, 2026 by Rhiannon Smith